Join Now

The voice of Utah’s life sciences community

Medical Devices

Pharmaceuticals

Diagnostics / Laboratory

Biotechnology

BioUtah is the common voice and flag bearer for Utah’s life sciences industry, comprised of medical devices, pharmaceuticals, diagnostics, laboratories, research facilities, and biotechnology of all types. BioUtah connects industry with government, academia, capital markets, media, and service providers. Together we form an ecosystem that fosters collaboration, promotes innovation, and delivers technology that saves lives.

Learn More

Icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY

Utah Life Sciences by the Numbers

Kem C. Gardner Report Findings Nov. 2023

Utah is #3 in the nation for life sciences growth.

Life sciences is a $21.6 billion industry in Utah.

Source: Pace, L. and Brandley, A. (2023), Economic Impacts of Utah’s Life Sciences and Health Care Innovation Industry: Utah’s Life Sciences and Health Care Innovation Industry Creates Substantial Economic Impacts Across the State, Kem C. Gardner Policy Institute, University of Utah.

BioUtah News

June 4, 2026
nView Medical Surpasses 1,000 Surgeries

nView medical announced that its nView s1 system has surpassed 1,000 surgeries, marking an important milestone in the clinical use of the company’s intraoperative 3D imaging and navigation technology.

June 4, 2026
NanoKar Therapeutics Receives Funding From the University of Utah Launchpad Seed Fund to Advance Next-Generation CAR-T Cell Therapy Platform

University of Utah Launchpad Seed Fund award to support translational validation of NanoKar’s ITAM optimization platform, including CAR-T persistence and activity in solid tumor models.

June 4, 2026
Ratio Therapeutics and PharmaLogic Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358

Expanded collaboration adds manufacturing capacity, strengthens redundancy, and supports later-stage development planning for Ratio’s lead FAP-targeted radiotherapeutic candidate.

May 28, 2026
Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)

New PATHOMIQ AI integration helps clinicians tailor active surveillance with greater confidence

May 28, 2026
Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara

Joint development strategy has been developed to address international deployment requirements if current outbreak continues or expands globally

May 28, 2026
NanoKar Therapeutics Announces Formal Appointment of Craig Mosman as Chief Executive Officer

Mosman to lead NanoKar’s next phase of translational validation, partner readiness, and strategic collaboration for its ITAM optimization platform

May 21, 2026
Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards

Recognition places Lumea among elite global winners including Medtronic and Thermo Fisher Scientific in one of digital health’s most competitive annual programs

May 21, 2026
Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert

Recent pathogens illustrate need for improved situational awareness capabilities, such as those provided by the Co-Dx PCR point-of-care platform

2025 Utah Life Sciences Award Recipients

Lifetime Achievement
Dr. Wes Sundquist

Innovation Impact
Nusano

Entrepreneur of the Year
Shawn Fojtik

Executive of the Year
Fred Lampropoulos

Friend of Industry
Dr. Taylor Randall

BioUtah is Powered by

Legacy Sponsors

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors